1. Raffel DM, Wieland DM (2010) Developmento of mIBG as a cardiac innervation imaging agent. J Am Coll Cardiol Img 3:111–116.
2. Hoefnagel CA, Lewington VJ (2004) MIBG therapy. In: Ell PJ, Gambhir SS (Eds) Nuclear medicine in clinical diagnosis and treatment, 3rd edition. Churchill Livingstone, Edinburgh, pp. 445–457.
3. Hoefnagel CA (1994) Metaiodobenzylguanidine and somatostatin in oncology: role in the management of neural crest tumours. Eur J Nucl Med 21:561–581.
4. Khafagi FA, Shapiro B, Fig LM et al (1989) Labetalol reduces Iodine-131 MIBG uptake by pheochromocytoma and normal tissues. J Nucl Med 30:481–489.
5. Reubi JC (1995) Neuropeptide receptors in health and disease: the molecular basis for in vivo imaging. J Nucl Med 36:1825–1835.